Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.01
Delayed Data
As of Dec 13
 -0.13 / -2.53%
Today’s Change
3.42
Today|||52-Week Range
6.31
+19.29%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Progenics Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 14.00 and a low estimate of 6.50. The median estimate represents a +39.72% increase from the last price of 5.01.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Progenics Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.26
Sales
$15.1M
Reporting Date
Mar 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -19.70%
 
 
 
 
 
 
Growthannually -15.33%
 
 
 
 
 
 

Sales

Growthquarterly 168.17%
 
 
 
 
 
 
Growthannually 103.47%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.